Stelfonta European Union - French - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - chiens - pour le traitement de la non-résécable non-métastatique (qui mise en scène) sous-cutanée de cellules de mât tumeurs situées au niveau ou en aval du coude ou de la pointe du jarret, et non résécable non métastatique cutanée de cellules de mât tumeurs chez les chiens.

Stelfonta European Union - Spanish - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - perros - para el tratamiento de la no resecable, no metastásico (que puesta en escena) subcutánea de los mastocitos de los tumores localizados en o distal al codo o el corvejón, y no resecable, no metastásico cutáneo de células cebadas tumores en perros.

Stelfonta European Union - Dutch - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - honden - voor de behandeling van non-resectable, niet-uitgezaaide (die staging) onderhuids mast-cel tumoren gelegen op of distaal van de elleboog of het spronggewricht en non-resectable, niet gemetastaseerd cutane mast-cel tumoren bij honden.

Stelfonta European Union - German - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - hunde - für die behandlung von nicht-resektablen, nicht metastasierten (die inszenierung) subkutan mast-zell-tumoren, die sich auf oder distal des ellenbogen-oder sprunggelenk, und nicht-resektablen, nicht metastasierten kutanen mast-zell-tumoren bei hunden.

Stelfonta European Union - Greek - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - Σκύλοι - Για τη θεραπεία της μη εξαιρέσιμος, μη-μεταστατικό (ΠΟΥ σταδιοποίηση) υποδόριος ιστός κυττάρων όγκων που βρίσκεται στο ή πάνω από τον αγκώνα ή τον ταρσό, και μη εξαιρέσιμος, μη μεταστατικό καρκίνο του δερματικού ιστού κυττάρων όγκοι σε σκύλους.

Stelfonta European Union - Italian - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol caprato - tigilanol caprato - cani - per il trattamento di non-resecabile, camere non-metastatico (che stadiazione) per via sottocutanea tumori delle cellule dell'albero si trova in corrispondenza o distale per il gomito o il garretto, e non resecabile, non metastasi cutanee di mastociti tumori nei cani.

Stelfonta European Union - English - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - dogs - for the treatment of non-resectable, non-metastatic (who staging) subcutaneous mast cell tumours located at or distal to the elbow or the hock, and non-resectable, non metastatic cutaneous mast cell tumours in dogs.

Tigilanol tiglate Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tigilanol tiglate

qbiotics group limited - tigilanol tiglate - unknown - tigilanol tiglate ester active 0.0 - active constituent

STABILANOL Israel - English - Ministry of Health

stabilanol

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: sta

STELFONTA Italy - Italian - Ministero della Salute

stelfonta

qbiotics netherlands b.v. - tigilanolo tiglato (tigilanol tiglate ebc-46) - tigilanolo tiglato (tigilanol tiglate ebc-46) - 1 mg - tigilanol tiglate